Gilead's Remdesivir authorised for emergency use only

COVID-19 drug Remdesivir's price in India is a concern; Pharma cos free to set price

Gilead Sciences' signs non-exclusive license pact with four Indian drug majors to set their own price for Covid-19 drug Remdesivir. Following this move, many pharma distributors have been selling the experimental drug at Rs 7000 per vial. This will result in escalated treatment cost, to procure vials approximating to Rs 35,000 to Rs 42,000 for five doses. Jun 5, 2020
Reliance Jio

Mukesh Ambani's RIL could sail through India's economic crisis unscathed: See how

At a time when the world economy has come to a standstill with businesses suffering huge losses, and companies deliberating on means and measures to tide over the Covid-19 crisis, Reliance Industries Limited (RIL) is riding high on success. RIL's Jio platform has managed to attract major investments in a span of just 3 weeks from Facebook, Silver Lake and Vista, in hopes to fortify the digital ecosystem in India and empower consumers in the near future. May 16, 2020